C13H18BBrO2
297 g/mol
Pharmaceutical IntermediateDanger
2-(4-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS138500-85-3EC679-122-7
Category
Pharmaceutical Intermediate
Compound Class
Organometallic
Primary Use
Pharmaceutical Intermediate
This compound is a boronic ester derivative containing a bromomethyl-substituted phenyl ring. It is primarily used as a building block in pharmaceutical manufacturing, particularly for the synthesis of active pharmaceutical ingredients.
Pharmaceutical intermediate for organic synthesisBuilding block in drug molecule construction
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 138500-85-3
Related Compounds
ReferenceSame Category
N,N-Bis[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide
CAS1385018-58-5
pharmaceutical intermediate
ReferenceSame Category
1-Bromo-3,4,5-trifluorobenzene
CAS138526-69-9
pharmaceutical intermediate
ReferenceSame Category
2-Amino-5-methylthiopene-3-carbonitrile
CAS138564-58-6
pharmaceutical intermediate
ReferenceSame Category
5-methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile
CAS138564-59-7
pharmaceutical intermediate
Safety Reference
Danger
H314Causes severe skin burns and eye damage
H318Causes serious eye damage
Identifiers
IUPAC Name
2-[4-(bromomethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
InChIKey
CBUOGMOTDGNEAW-UHFFFAOYSA-N
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)CBr
Synonyms (7)
—